piperacillin has been researched along with Soft Tissue Infections in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ourique, C; Rego-Costa, F; Torres-Ramalho, P | 1 |
| Hayashi, Y; Katayama, M; Suzuki, D; Takimoto, K; Wang, Q | 1 |
| Demetriou, M; Maltezos, E; Panagopoulos, P; Panopoulou, M; Papanas, N | 1 |
| Kaempfen, A; Mijuskovic, B; Wiggli, B | 1 |
| Azouri, T; Bathina, P; Kandipalli, D; Kaplansky, T; Kaye, KS; Lazarovitch, T; Marchaim, D; Maskit, M; Ofer-Friedman, H; Sharma, S; Shefler, C; Tal-Jasper, R; Tirosh, A; Zaidenstein, R | 1 |
| Havey, TC; Hull, MW; Leung, V; Romney, MG | 1 |
| Beerle, C; Breitenstein, S; Gelpke, H; Staerkle, RF | 1 |
| Brunner, M; Erovic, BM; Georgopoulos, A; Joukhadar, C; Marsik, C; Müller, M; Sauermann, R; Zeitlinger, M | 1 |
| Dittrich, P; Hoffmann, C; Kerl, H; Krause, R; Legat, FJ; Salmhofer, W; Scholz, S; Tscherpel, J; Tscherpel, T; Zenahlik, P | 1 |
| Kuti, JL; Nicolau, DP; Ong, CT | 1 |
| Antoine, TL; Blumberg, HM; Cardo, D; Curtis, AB; Desilva, K; Fransua, M; Gaynes, RP; Gould, CV; Jernigan, JA; King, M; Kraman, AA; Pack, J; Ribner, B; Seybold, U; Sinkowitz-Cochran, RL; Steinberg, JP; Wells, JB | 1 |
| Dilay, L; Gin, A; Karlowsky, JA; Rubinstein, E; Walkty, A; Zhanel, GG | 1 |
| Kinzig, M; Sörgel, F | 1 |
| File, TM; Tan, JS | 2 |
| Jones, RN | 1 |
| Blatun, LA; Iakovlev, VP; Izotova, GN; Svetukhin, AM; Terekhova, RP | 1 |
| LaFleur, BJ; Siami, FS; Siami, GA | 1 |
6 review(s) available for piperacillin and Soft Tissue Infections
| Article | Year |
|---|---|
Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fluoroquinolones; Humans; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome | 2017 |
Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Soft Tissue Infections | 2007 |
Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam; Tissue Distribution | 1994 |
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Ticarcillin | 1994 |
Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Soft Tissue Infections; Tazobactam | 1995 |
Treatment of skin and soft-tissue infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Fasciitis; Humans; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases; Soft Tissue Infections; Surgical Wound Infection; Tazobactam | 1995 |
2 trial(s) available for piperacillin and Soft Tissue Infections
| Article | Year |
|---|---|
[Clinico-laboratory study of piperacillin/tazobactam in the treatment of patients with would infection].
Topics: Adolescent; Adult; Aged; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Laboratories; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Recurrence; Soft Tissue Infections; Wound Infection | 1997 |
Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Dermatitis, Phototoxic; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitals, Veterans; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Skin Diseases, Infectious; Soft Tissue Infections; United States | 2002 |
10 other study(ies) available for piperacillin and Soft Tissue Infections
| Article | Year |
|---|---|
Unusual course of a haematoma of the thigh.
Topics: Anti-Bacterial Agents; Delayed Diagnosis; Drainage; Female; Hematoma; Humans; Linezolid; Magnetic Resonance Imaging; Middle Aged; Muscle, Skeletal; Osteomyelitis; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam; Thigh | 2017 |
Antibiotic Resistance in Diabetic Foot Soft Tissue Infections: A Series From Greece.
Topics: Aged; Anti-Bacterial Agents; Biological Availability; Diabetic Foot; Drug Resistance, Microbial; Female; Greece; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Soft Tissue Infections | 2017 |
A rare and dangerous hand infection caused by Francisella tularensis after a mouse bite.
Topics: Animals; Anti-Bacterial Agents; Bites and Stings; Debridement; Hand; Hospitalization; Humans; Infusions, Intravenous; Male; Mice; Piperacillin; Soft Tissue Infections; Tazobactam; Tularemia; Young Adult | 2018 |
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Intraabdominal Infections; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections | 2015 |
Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: Opportunities for antimicrobial stewardship.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Utilization; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Skin Diseases, Infectious; Soft Tissue Infections | 2015 |
Complicated acute appendicitis presenting as a rapidly progressive soft tissue infection of the abdominal wall: a case report.
Topics: Abdominal Pain; Abdominal Wall; Anti-Bacterial Agents; Appendectomy; Appendicitis; Emphysema; Escherichia coli Infections; Female; Humans; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Reoperation; Soft Tissue Infections; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model.
Topics: Colony Count, Microbial; Critical Illness; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Diabetic Foot; Extracellular Fluid; Female; Humans; Inflammation; Male; Microdialysis; Middle Aged; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam | 2005 |
Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Prevalence; Soft Tissue Infections; Thienamycins | 2005 |
Knowledge, attitudes, and behaviors regarding piperacillin-tazobactam prescribing practices: results from a multicenter study.
Topics: Anti-Bacterial Agents; Drug Utilization; Focus Groups; Health Knowledge, Attitudes, Practice; Hospitals, University; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Practice Patterns, Physicians'; Skin Diseases, Infectious; Soft Tissue Infections | 2006 |